Skip to content
Open access · CC-BY via OpenAlex

Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts

Sayantan Jana, Hao Zhang, Gary D. Lopaschuk, Darren H. Freed, Consolato Maria Sergi, Paul Fraser Kantor, Gavin Y. Oudit, Zamaneh Kassiri

Journal of the American Heart Association · 2018 · ▲ 34 citations

Abstract

Background Dilated cardiomyopathy (DCM) is a common cause of heart failure in adult and pediatric patients, but the underlying mechanism may vary in adults and children, with few studies conducted to date. The objective of the present study was to determine whether differential remodeling of the extracellular matrix contributes to the differences between pediatric and adult DCM hearts. Methods and Results Explanted hearts were procured from adult (age, 46-61 years) and pediatric (age, 2-8) patients with DCM-related heart failure and nonfailing control hearts. Fibrillar and nonfibrillar extracellular matrix (proteoglycans, glycosaminoglycans, glycoprotein), their regulatory enzymes (matrix metalloproteinases, disintegrin and metalloproteinases, and disintegrin and metalloproteinases with a thrombospondin domain), and their inhibitors (tissue inhibitor of metalloproteinases) were assessed. Pediatric DCM hearts exhibited less fibrosis compared with adult DCMs. Total glycosaminoglycans increased similarly in both DCM groups but exhibited a significantly lower affinity for transforming growth factor-β in adult DCMs versus pediatric DCMs, resulting in increased bioavailability of transforming growth factor-β1 and a significantly higher activity of the Smad2/3 pathway in adult DCMs. Glycosylated biglycan and versican, and cleaved thrombospondin-1 increased in both DCMs. Protein expression of disintegrin and metalloproteinases with thrombospondin domains (-1, -2, -4, -7) and disintegrin and metalloproteinases (-12, -15, -17, -19) were altered differently in pediatric and adult control and failing hearts. Total matrix metalloproteinase activity increased in both DCMs. Tissue inhibitor of metalloproteinase levels were altered similarly with heart failure in both age groups, and only tissue inhibitor of metalloproteinase 3 decreased in both DCM groups. Conclusions Differential remodeling of glycosaminoglycans in pediatric DCMs versus adult DCMs could underlie the enhanced activation of the transforming growth factor-β pathway, leading to more fibrosis in adult DCM hearts. The distinct remodeling of the fibrillar and nonfibrillar extracellular matrix between pediatric and adult DCM hearts highlights a distinct pathophysiological basis for these cohorts.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1161/jaha.118.010427
Canonical
link ↗
Fetched
2026-10-25 MST

Cite this

APA
Jana, S., Zhang, H., Lopaschuk, G.D., Freed, D.H., Sergi, C.M., Kantor, P.F., Oudit, G.Y., &amp; Kassiri, Z. (2018). Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts. <em>Journal of the American Heart Association</em>. https://doi.org/10.1161/jaha.118.010427
Vancouver
Jana S, Zhang H, Lopaschuk GD, Freed DH, Sergi CM, Kantor PF, et al. Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts. Journal of the American Heart Association. 2018. doi:10.1161/jaha.118.010427.
BibTeX
@article{sayantan2018Dispar, title = {Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts}, author = {Sayantan Jana and Hao Zhang and Gary D. Lopaschuk and Darren H. Freed and Consolato Maria Sergi and Paul Fraser Kantor and Gavin Y. Oudit and Zamaneh Kassiri}, journal = {Journal of the American Heart Association}, year = {2018}, doi = {10.1161/jaha.118.010427}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings